Form 4: ASP Isotopes Director Receives Annual Stock Award
Insider Transaction Report
ASP Isotopes Inc. Director Michael Gorley received an annual award of 36,548 shares of restricted common stock, increasing his beneficial ownership to 117,908 shares.
Summary
- Michael Gorley, a Director of ASP Isotopes Inc. (ASPI), acquired 36,548 shares of common stock.
- This transaction occurred on December 18, 2025.
- The acquisition was an annual award of restricted stock in connection with his service as an independent director.
- Following this transaction, Gorley beneficially owns a total of 117,908 shares of ASP Isotopes Inc. common stock.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as the transaction represents a routine compensation award to a director, aligning their interests with shareholders. It is not highly impactful but generally viewed favorably.
Positives
- The acquisition of shares by Director Michael Gorley aligns his financial interests with those of shareholders.
- The award is part of a routine annual compensation for his service as an independent director, indicating stable corporate governance practices.
Negatives
- No negative aspects are directly discernible from this routine insider transaction filing.
Future Outlook
This filing does not contain forward-looking statements or guidance, as it is a report of a completed insider transaction.
Industry Context
This filing is a standard disclosure of an insider equity transaction and does not provide information related to broader industry trends or competitors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | The annual award of restricted stock to an independent director is a standard practice for director compensation, reflecting established corporate governance policies regarding non-employee director remuneration. | 12/18/2025 | Reinforces alignment of director interests with long-term shareholder value. |
Related Party Transactions
- The transaction involves the issuance of 36,548 shares of common stock by ASP Isotopes Inc. to Michael Gorley, an independent director, as part of his annual compensation for service.
Stakeholder Impact
- Shareholders: The transaction aligns the director's financial interests with those of the shareholders, potentially encouraging decisions that benefit long-term stock value.
- Employees: No direct impact on employees is indicated by this filing.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 12/18/2025 | Date of transaction where Michael Gorley acquired common stock. |
| 12/22/2025 | Date the Form 4 was signed by Donald Ainscow, as attorney-in-fact. |
Keywords
ASP Isotopes Inc., ASPI, Michael Gorley, Director, Insider Transaction, Form 4, Stock Award, Restricted Stock, Equity Compensation, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.